With nearly a decade working in the rapidly evolving industry, I’ve noticed a variety of reasons why the pitch process, relationships between digital/social experts, account teams at agencies and properly following through on execution are not working smoothly. This is one of the core reasons behind Pharma’s lack of progress – not to minimize regulatory hurdles at all – but we also need to recognize that traditional PR, advertising, marketing processes and people are being deployed into what is a very complex, dynamic environment. Continue reading A Call for the Digital/Social Expert [Consultant] as a Priority Partner
Facebook. The land where the “Like” is commonly the number one goal. I had a client mention that he was intent on getting more Page Likes, a common ask that persists even as the platform transforms around us. Page Likes have become a vanity metric, looking good on the outside, but fairly shallow when examinedContinue reading Facebook: The Power is in the Timeline
Still waiting for the FDA to tell Pharma what we can do in Social Media? Folks, we already have our guidelines. Reading an old article last night (note: from Jan 2014) made me realize some of the real reasons behind Pharma’s struggle with social media – and it’s not because of the FDA or lack of guidance. While theContinue reading Pharma, We Already Have Our FDA Social Media Guidelines
In my eyes, we’ve only uncovered the tip of the iceberg for health and mobile, it has always just been a matter of avoiding the giant block of ambiguous ice that lives underneath that tip – but with the proper navigation, the opportunity for innovation and success is unlimited. The caution comes mostly in the fear of riskContinue reading Pharma Mobile Apps Are Not Dead and Kudos Sanofi, But More Can Be Done
Search and the fact that a mobile device may already be in a physician’s hand during a patient visit offers a unique opportunity – let’s use that device to better communicate information about a disease or condition to the patient in a way they are more likely to understand. Technology allows touch interaction, video provides a visual means of understanding. Memorability even comes merely in the form of awe in how cool an app may be, leading one to explore others like it.Continue reading Mobile Apps & Search to Enhance Doctor-Patient Discussions
The most successful community managers will be passionate about their work, which means the content they’re sharing will be higher quality and the conversations they are having more relevant. Personality, enthusiasm and expertise in the topics shows true commitment, which entices engagement and builds trust within the community – especially as it relates to health. Community Managers – theContinue reading Community Managers: Striking a Balance Between Passion and Experience
Facebook’s recent newsfeed algorithm change has presented an indirect a wake-up call for pharma: it’s time to learn how to be social. It’s more imperative than ever to garner engagement on your posts, so adapt accordingly. But why is it that pharma has struggled to be successful in what may arguably be one of the mostContinue reading HEY PHARMA! Time to Embrace Being Social.
This one’s tricky. As a digital strategist, I ask myself this question all the time and have almost too much of a hard time explaining it when asked. The truth is that digital strategy is fairly intangible. It’s a combination of experience rooted in many different fields and it means balancing those fields to meetContinue reading What Exactly is this “Digital Strategy” Thing?
With a recent Pew Research Study reporting that 30 percent of US adults get their news on Facebook, 43 percent saying that they post or share links to news stories and 60 percent noting that they like or comment on news stories, Facebook is beginning to focus their brand page/newsfeed algorithm on “high-quality stories”. ThisContinue reading Explained: Facebook Page Newsfeed Algorithm Changes
Translation: What aspects of social media is pharma responsible for and the process for interacting in real-time while adhering to FDA postmarketing submission guidelines. On the path to releasing full guidance for pharma promotional activities in social media in July 2014, yesterday, the Food and Drug Administration (FDA) released draft guidance for comment, specific toContinue reading Explained: New FDA Guidance on Fulfilling Regulatory Requirements for Postmarketing Submissions of Interactive Promotional Media